Avalyn Pharma Alternatives & Competitors
12 companies similar to Avalyn Pharma — Revolutionizing respiratory care with every breath
Companies similar to Avalyn Pharma
Genoa Pharmaceuticals
Pioneering a breath of hope with innovative therapies for idiopathic pulmonary fibrosis si...
Kither Biotech
Improving treatment for patients suffering from incurable respiratory diseases
Turin, Italy
Stockholm, Sweden
Track all Avalyn Pharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Pulmatrix Inc.
Changing medicine with a new generation of pulmonary-delivered therapeutics
Bedford, United States
Savara Inc.
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases....
United States
Ultragenyx
Going Beyond Every Day
Novato, United States
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
Cytokinetics
Empowering Muscle Empowering Lives
South San Francisco, Unit...
Lumos Pharma
Transforming Lives with Rare Focus
Austin, United States
Bloomsbury Genetic Therapies
Dedicated to delivering the promise of gene therapy
London, United Kingdom
Cullinan Therapeutics
Science That Moves
Cambridge, United States
About Avalyn Pharma
Avalyn Pharma, founded in 2011 and headquartered in the United States, is pioneering advancements in the treatment of pulmonary fibrosis. With the slogan, “Revolutionizing respiratory care with every breath,” Avalyn is focused on creating innovative inhaled therapies. The company is reshaping respiratory medicine with...
Development of inhaled therapies, Drug delivery solutions, Clinical trials
Patients with rare lung diseases, Healthcare providers, Biopharmaceutical investors
Pulmonary Fibrosis Treatment, Respiratory Care, Inhaled Formulations, Interstitial Lung Diseases, Pirfenidone, Nintedanib, Idiopathic Pulmonary Fibrosis, Biopharma Company, Therapeutics Development, Lung Exposure, Systemic Exposure Reduction, Phase 2b MIST Study, Optimized Inhaled Therapies, Severe Respiratory Diseases, Drug Formulation
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Avalyn Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Avalyn Pharma on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
